BEAM vs ED · rev $63.5M vs P/E 18, rev $15.26B
Beam Therapeutics Inc (BEAM) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
BEAM currently screens at market cap $2.01B. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the BEAM and ED stock pages for the full models.
Not investment advice.